Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology
about
Immune response and immunopathology during toxoplasmosisInterleukin-27: balancing protective and pathological immunityProtection and pathology during parasite infection: IL-10 strikes the balanceBiology of IL-27 and its role in the host immunity against Mycobacterium tuberculosisIL-27 receptor signalling restricts the formation of pathogenic, terminally differentiated Th1 cells during malaria infection by repressing IL-12 dependent signalsRegulation of immunity during visceral Leishmania infectionCombined Immune Therapy for the Treatment of Visceral LeishmaniasisTimed action of IL-27 protects from immunopathology while preserving defense in influenzaImmune regulation during chronic visceral leishmaniasis.Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells.Role of interleukin 10 transcriptional regulation in inflammation and autoimmune diseaseAAV2-mediated subretinal gene transfer of mIL-27p28 attenuates experimental autoimmune uveoretinitis in micegp130 at the nexus of inflammation, autoimmunity, and cancer.IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasisSuppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27IL-27-induced modulation of autoimmunity and its therapeutic potential.The WSX-1 pathway restrains intestinal T-cell immunityIL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization.Balancing immunity and pathology in visceral leishmaniasis.Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses.IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis.Role and therapeutic value of dendritic cells in central nervous system autoimmunity.Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.A role for IL-27 in limiting T regulatory cell populations.Transcriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding.Type 1 regulatory T cells (Tr1) in autoimmunityInduction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.IL-27 Signaling Is Crucial for Survival of Mice Infected with African Trypanosomes via Preventing Lethal Effects of CD4+ T Cells and IFN-γ.T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?Elevated circulating interleukin-27 in patients with coronary artery disease is associated with dendritic cells, oxidized low-density lipoprotein, and severity of coronary artery stenosis.Interleukin-12 and tuberculosis: an old story revisitedThe cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology.Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-MafTemporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection.IL27: its roles in the induction and inhibition of inflammation.Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice.Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.IL-27 Induced by Select Candida spp. via TLR7/NOD2 Signaling and IFN-β Production Inhibits Fungal Clearance.Negative regulation of Th17 responses
P2860
Q24612341-EFAF230B-7D91-4B4B-BA11-D371BB98D10EQ26830400-91361E36-B773-45F8-AB68-2B78F35915E5Q27005837-F6012406-4783-4A05-8706-0E9E2B9D133EQ27014743-BF32B3DF-99BC-4A59-939C-51D6CD0EC99FQ27335198-716BDA4D-51ED-4851-8442-6A34443A4663Q28066034-0CBFD037-06AA-47B3-8573-4E0258063870Q28550162-F16BB8E3-2ADC-41AB-AE06-4746F6A418FCQ33583784-C0ACDEC8-572E-4057-B24F-C719EFB79750Q33881718-5BFAE5EE-A58F-4A0E-AED9-6573896E816FQ34242160-1DB29562-24C7-4304-A931-B0590CC0C66FQ34262223-A7606990-3771-4A7E-A54F-843CBB5CF20BQ34282130-5E147576-E67F-4D55-8BA3-0A8891BCC17CQ34378756-555C33C9-9171-4C35-BDEF-AC14C04FFB22Q34387183-F96BB8E0-01B9-464A-A0DC-9A0050F200D2Q34482169-5E493F83-0C3B-46B7-BE30-57B9343E1A7FQ34488727-14740425-585F-44D2-B6EA-8C9D83F6A431Q34538706-29720585-4ABC-4016-AE0E-475008C47772Q34581324-40A48837-1AB9-4E67-829E-D77184D3EFD9Q34587432-B539752F-96F8-4E57-9643-6C7F9D8A6DBDQ34721430-DBA13CA4-0BB4-4184-B222-6B3D41016FBBQ34756202-9E362CD8-BA89-48B6-961E-AB36E78E359BQ34792941-EB1F6062-F8B6-4A52-8175-B8CFC075844AQ34924088-2702727F-70A1-42F9-BFDB-1E8F809B1562Q34955529-D5764D1A-68F9-483E-BBDE-A365FD1399FFQ35058908-6AA503B6-7D1F-4DAA-A0CA-DEDD2A4C1844Q35148364-F4D2CCED-351F-423D-A68F-664C5C8B5F81Q35226496-AA53EA94-D3D9-4EBF-849E-B1168F5EB6D2Q35592657-0662ABD0-F1E8-41A7-93C9-C88972F27717Q35722876-B6324BEF-AF22-4250-AD40-54B90B8214B0Q35928348-F1791B07-5B5C-4F2B-AC12-6C803CE5F12DQ36111544-FA24E2E6-1DA2-4162-B25B-FFFAC3143C96Q36137298-E3061D95-DD64-4C2C-B5CB-81AAB143CCD0Q36336588-491D660A-DB5F-42C0-AA9B-54D5988432E6Q36399138-764EB8B9-11DD-4D46-93F1-5D7E51AD7C34Q36422101-3C79D6BA-1A86-4DBE-989E-B77D123F67F2Q36784915-2AF17D9A-3E98-4677-AB92-8D04A5E0DE31Q36845171-B3B10C0C-A5A2-47E7-8309-287546E82722Q36970905-F5BB55CB-3942-4C43-9189-17676ADFF842Q37015050-95E02610-1E0D-4AED-8DC4-0BF6B3983AC4Q37067780-E101FEE9-AD1E-4098-88C0-F612B24C9DC3
P2860
Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Interleukin-27R (WSX-1/T-cell ...... p severe liver immunopathology
@ast
Interleukin-27R (WSX-1/T-cell ...... p severe liver immunopathology
@en
type
label
Interleukin-27R (WSX-1/T-cell ...... p severe liver immunopathology
@ast
Interleukin-27R (WSX-1/T-cell ...... p severe liver immunopathology
@en
prefLabel
Interleukin-27R (WSX-1/T-cell ...... p severe liver immunopathology
@ast
Interleukin-27R (WSX-1/T-cell ...... p severe liver immunopathology
@en
P2093
P2860
P1476
Interleukin-27R (WSX-1/T-cell ...... p severe liver immunopathology
@en
P2093
Abhay R Satoskar
Anjali A Satoskar
Christopher Hunter
Frederic J de Sauvage
Joseph Barbi
Kimberly M Roth
Lucia E Rosas
Tracy L Keiser
P2860
P304
P356
10.2353/AJPATH.2006.050013
P407
P577
2006-01-01T00:00:00Z